Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses on interferon-alpha2a in patients with HIV

Authors :: Fischl, Margaret A.
Richman, Douglas D.
Saag, Michael
Meng, Tze Chiang
Squires, Kathleen E.
Holden-Wiltse, JEanne
Meehan, Patricia M.
Source :: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. Dec 1, 1997, Vol. 16 Issue 4, p247, 7 p.
Publication Year :: 1997
Abstract: This is the result of a randomized trial to determine how effective, if at all, a combination of zidovudine, zalcitabine and interferon alpha 2a might be for patients with HIV infection. The interferon was temporarily effective but at the cost of increasing blood toxicity and causing unpleasant side effects.

Subjects :: Zidovudine -- Health aspects
Zalcitabine -- Health aspects
Interferon alpha -- Health aspects
Drug therapy, Combination -- Evaluation
HIV infection
Health

ISSN :: 10779450
Volume :: 16
Issue :: 4
Database :: Gale General OneFile
Journal :: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Publication Type :: Periodical
Accession number :: edsgcl.55341765

Tools